Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs
- 5 July 2007
- journal article
- research article
- Published by Springer Nature in Zeitschrift Fur Parasitenkunde-Parasitology Research
- Vol. 101 (5) , 1319-1322
- https://doi.org/10.1007/s00436-007-0638-0
Abstract
Cutaneous leishmaniasis (CL) is a major health problem in endemic areas of Iran. The pentavalent antimony (SbV) based drug Glucantime is the first line of treatment for CL in Iran, but recently SbV-resistant Leishmania tropica isolates derived from unresponsive patients were reported. We show in this study that these resistant parasites are cross-resistant to the other SbV-containing drug Pentostam and at least for one isolate also to amphotericin B. However, these resistant isolates were shown to be sensitive to miltefosine and paromomycin. The latter two drugs could thus be useful alternatives for the treatment of leishmaniasis in Iran even for SbV-resistant isolates.Keywords
This publication has 26 references indexed in Scilit:
- A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell DeathMolecular & Cellular Proteomics, 2007
- American Tegumentary Leishmaniasis: Is Antimonial Treatment Outcome Related to Parasite Drug Susceptibility?The Journal of Infectious Diseases, 2006
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica ParasitesPLoS Medicine, 2006
- Drug Resistance in LeishmaniasisClinical Microbiology Reviews, 2006
- Advances in leishmaniasisPublished by Elsevier ,2005
- Gene Expression Analysis of the Mechanism of Natural Sb(V) Resistance in Leishmania donovani Isolates from NepalAntimicrobial Agents and Chemotherapy, 2005
- Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental modelsZeitschrift Fur Parasitenkunde-Parasitology Research, 2005
- DNA Transformation of Leishmania infantum Axenic Amastigotes and Their Use in Drug ScreeningAntimicrobial Agents and Chemotherapy, 2001
- In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patientsJournal of Antimicrobial Chemotherapy, 2001
- Leishmania(V.)guyanensis: isolation and characterization of glucantime-resistant cell linesCanadian Journal of Microbiology, 1996